26.07USD+0.70%Mkt Cap: 1.80B USDP/E: —Last update: 2026-05-26
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap1.80B USD
Enterprise Value1.71B USD
Revenue (TTM)751.00K USD
Gross Profit-189.00K USD
Net Income (TTM)-72.78M USD
Revenue/Share0.0110 USD
Last Price26.07 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees116
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS74587B1017
Valuation
P/E (Trailing)—
P/E (Forward)-29.05
PEG—
EV/EBITDA-22.35
EV/Revenue2274.08
P/S2355.53
P/B21.50
EPS (TTM)-1.10
EPS (Forward)-0.88
52W Range
12.5688% of range27.98
52W High27.98 USD
52W Low12.56 USD
Profitability
Gross Margin-54.00%
Oper. Margin-4775.56%
EBITDA Margin0.00%
Profit Margin-20794.57%
ROE-90.24%
ROA-76.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.12M USD
CapEx (TTM)335.00K USD
FCF Margin-3872.19%
FCF Yield-1.61%
Net Debt-61.16M USD
Net Debt/EBITDA0.80
Balance Sheet
Debt/Equity0.09
Current Ratio7.26
Quick Ratio6.99
Book Value/Sh1.189 USD
Cash/Share0.9870 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)30.00 USD
Target Range30.00 USD – 30.00 USD
# Analysts2
Ownership
Shares Out.69.21M
Float18.40M
Insiders73.38%
Institutions11.58%
Short Interest
Short Ratio11.5d
Short % Float16.00%
Short % Out.4.29%
Shares Short2.92M
Short (prev mo.)2.92M
Technical
SMA 5021.86 (+19.3%)
SMA 20017.72 (+47.2%)
Beta1.63
S&P 52W Chg28.31%
Avg Vol (30d)336.05K
Avg Vol (10d)521.27K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—